Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma.

Al Abbas, Amr I; Zenati, Mazen; Rieser, Caroline J; Hamad, Ahmad; Jung, Jae Pil; Zureikat, Amer H; Zeh, Herbert J; Hogg, Melissa E

Al Abbas, Amr I; Zenati, Mazen; Rieser, Caroline J; Hamad, Ahmad; Jung, Jae Pil; Zureikat, Amer H; Zeh, Herbert J; Hogg, Melissa E.

Afiliação

Al Abbas AI; University of Pittsburgh, Pittsburgh, PA, USA.
Zenati M; University of Texas Southwestern, Dallas, TX, USA.
Rieser CJ; University of Pittsburgh, Pittsburgh, PA, USA.
Hamad A; University of Pittsburgh, Pittsburgh, PA, USA.
Jung JP; University of Pittsburgh, Pittsburgh, PA, USA.
Zureikat AH; Ohio State University, Columbus, OH, USA.
Zeh HJ; University of Pittsburgh, Pittsburgh, PA, USA.
Hogg ME; Andong Medical Group Hospital, Andong-si, Gyeongbuk, Korea.

Ann Surg Oncol ; 27(Suppl 3): 965, 2020 Dec.

Article em En | MEDLINE | ID: mdl-32034575

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google